Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 91200
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.91200
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.91200
Figure 8 Pathogenesis of diabetic encephalopathy.
PI3K: Phosphatidylinositol 3-kinase; AMPK: Adenosine monophosphate-activated protein kinase; mTOR: Mechanistic target of rapamycin; Bcl-2: B cell leukemia/lymphoma 2; Bax: B cell leukemia/lymphoma 2-associated X; NLRP3: NLR family pyrin domain containing 3; IL: Interleukin; TNF-α: Tumor necrosis factor α.
- Citation: Ye XW, Zhang HX, Li Q, Li CS, Zhao CJ, Xia LJ, Ren HM, Wang XX, Yang C, Wang YJ, Jiang SL, Xu XF, Li XR. Scientometric analysis and historical review of diabetic encephalopathy research: Trends and hotspots (2004-2023). World J Diabetes 2025; 16(5): 91200
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/91200.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.91200